Serum Levels of Soluble Interleukin-2 Receptor in Patients with Perennial Allergic Rhinitis Before and After Immunotherapy
- 30 September 1996
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 77 (3) , 203-208
- https://doi.org/10.1016/s1081-1206(10)63256-5
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (07671878)
This publication has 13 references indexed in Scilit:
- Immunotherapy in EuropeClinical and Experimental Allergy, 1994
- Proinflammatory cytokines in acute asthmaThe Lancet, 1991
- Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseasesClinical and Experimental Immunology, 1991
- T Lymphocytes and Their Products in Atopic Allergy and AsthmaInternational Archives of Allergy and Immunology, 1991
- Expression of Scrum IL-2, IL-2R, and CD8 Levels During Hyposensitization in House-Dust-Sensitive AsthmaticsJournal of Asthma, 1990
- T LYMPHOCYTE ACTIVATION IN ACUTE SEVERE ASTHMAThe Lancet, 1988
- The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.Environmental Health Perspectives, 1987
- The Biochemistry, Biology, and Role of Interleukin 2 in the Induction of Cytotoxic T Cell and Antibody‐Forming B Cell ResponsesImmunological Reviews, 1982
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976